Tag Archives: Doron Therapeutics

Doron Therapeutics 11m Series A Osteoporosis Drug Phase 3 Clinical Study

BIOTECH

Doron Therapeutics Raises $11M Series A to Progress Biologic Regenerative Osteoarthritis Drug into Phase 3 Clinical Studies
November 25, 2024

CHAPEL HILL, NC / ACCESSWIRE / November 25, 2024 / Doron Therapeutics, a clinical-stage biotech company...

Read more
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.
Accept